Literature DB >> 27295026

Neuronal-derived Ccl7 drives neuropathic pain by promoting astrocyte proliferation.

Bin Chang Ke1, Xia Xiao Huang, Yang Li, Li Ya Li, Qin Xue Xu, Yan Gao, Yingju Liu, Jie Luo.   

Abstract

Recent studies suggest that peripheral nerve injury converts resting spinal cord astroglial cells into an activated state, which is required for the development and maintenance of neuropathic pain. However, the underlying mechanisms of how resting astrocytes are activated after nerve injury remain largely unknown. Astroglial cell proliferation and activation could be affected by endogenous factors including chemokines, growth factors, and neurotropic factor. Chemokine (C-C motif) ligand 7 (Ccl7) is essential in facilitating the development of neuropathic pain; however, the mechanism is unknown. In the present study, we found that Ccl7 promoted astrocyte proliferation and thus contributed toward neuropathic pain. Spinal nerve ligation increased the expression in the spinal cord of neuronal Ccl7. Behavioral analyses showed that knockdown of Ccl7 alleviated spinal nerve ligation-induced neuropathic pain. Further in-vitro study showed that neuronal-derived Ccl7 was sufficient for the proliferation and activation of astroglial cells. We found a novel mechanism of Ccl7 stimulating the proliferation and activation of spinal cord astrocytes that contributes toward neuropathic pain.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27295026     DOI: 10.1097/WNR.0000000000000625

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  6 in total

1.  The blockade of CC chemokine receptor type 1 influences the level of nociceptive factors and enhances opioid analgesic potency in a rat model of neuropathic pain.

Authors:  Katarzyna Pawlik; Anna Piotrowska; Klaudia Kwiatkowski; Katarzyna Ciapała; Katarzyna Popiolek-Barczyk; Wioletta Makuch; Joanna Mika
Journal:  Immunology       Date:  2020-02-05       Impact factor: 7.397

Review 2.  The therapeutic potential of targeting chemokine signalling in the treatment of chronic pain.

Authors:  Karli Montague; Marzia Malcangio
Journal:  J Neurochem       Date:  2017-02-24       Impact factor: 5.372

3.  Investigation of Key Genes and Pathways in Inhibition of Oxycodone on Vincristine-Induced Microglia Activation by Using Bioinformatics Analysis.

Authors:  Wei Liu; Jishi Ye; Hong Yan
Journal:  Dis Markers       Date:  2019-02-10       Impact factor: 3.434

4.  Irisin promotes C2C12 myoblast proliferation via ERK-dependent CCL7 upregulation.

Authors:  Jangho Lee; Joon Park; Young Ho Kim; Nam Hyouck Lee; Kyung-Mo Song
Journal:  PLoS One       Date:  2019-09-13       Impact factor: 3.240

5.  Blockade of CC Chemokine Receptor Type 3 Diminishes Pain and Enhances Opioid Analgesic Potency in a Model of Neuropathic Pain.

Authors:  Katarzyna Pawlik; Agata Ciechanowska; Katarzyna Ciapała; Ewelina Rojewska; Wioletta Makuch; Joanna Mika
Journal:  Front Immunol       Date:  2021-11-02       Impact factor: 7.561

6.  Metamizole relieves pain by influencing cytokine levels in dorsal root ganglia in a rat model of neuropathic pain.

Authors:  Renata Zajaczkowska; Klaudia Kwiatkowski; Katarzyna Pawlik; Anna Piotrowska; Ewelina Rojewska; Wioletta Makuch; Jerzy Wordliczek; Joanna Mika
Journal:  Pharmacol Rep       Date:  2020-07-20       Impact factor: 3.024

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.